Okyo Pharma Stock Price, News & Analysis
Company Description
Okyo Pharma (OTC: EMMLF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $22.7M.
EMMLF stock has declined 82.5% over the past year.
This page provides a comprehensive overview of EMMLF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Okyo Pharma (EMMLF) stock. Over the past 12 months, the stock has lost 82.5%. At a market capitalization of $22.7M, EMMLF is classified as a micro-cap stock with approximately 1.7B shares outstanding.
Latest News
Okyo Pharma has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include offering, IPO, fda approval. View all EMMLF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
EMMLF Company Profile & Sector Positioning
Okyo Pharma (EMMLF) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing EMMLF often look at related companies in the same sector, including Neuraxis Inc (NRXS), Fibrobiologics (FBLG), CytoMed Therapeutics Ltd (GDTC), Stealth Biotherapeutics (MITO), and Nanoviricides (NNVC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EMMLF's relative position within its industry.